Yes, Circadin is a prescription-grade melatonin approved by HSA as a monotherapy for the short term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
Yes, Circadin is a prescription-grade melatonin approved by HSA as a monotherapy for the short term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.